Metropolitan Life Insurance Company (MetLife)’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,876
Closed -$57K 2529
2017
Q3
$57K Hold
3,876
﹤0.01% 2443
2017
Q2
$406K Hold
3,876
﹤0.01% 1857
2017
Q1
$497K Hold
3,876
﹤0.01% 1658
2016
Q4
$347K Buy
3,876
+711
+22% +$53.9K ﹤0.01% 1988
2016
Q3
$233K Hold
3,165
﹤0.01% 2241
2016
Q2
$210K Buy
+3,165
New +$180K ﹤0.01% 2292
2016
Q1
Sell
-2,814
Closed -$209K 2529
2015
Q4
$209K Hold
2,814
﹤0.01% 2242
2015
Q3
$195K Hold
2,814
﹤0.01% 2302
2015
Q2
$257K Buy
+2,814
New +$285K ﹤0.01% 2229
2014
Q3
Sell
-1,454
Closed -$245K 2737
2014
Q2
$245K Buy
+1,454
New +$251K ﹤0.01% 2358

Other funds holding ARAV

Metropolitan Life Insurance Company (MetLife)'s ARAV Position: Q4 2017 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2017, closing a stake of 3,876 shares — an estimated $57K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARAV in Q2 2014 and held it in 10 quarters. The position peaked at $497K in Q1 2017. 85 funds tracked by Wall St. Rank hold ARAV as of Q4 2017.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Aravive, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,876 Aravive, Inc. Common Stock shares in Q4 2017, an estimated $57K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Aravive, Inc. Common Stock position peaked at $497K in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2017.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.